ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II study of sunitinib as second-line treatment in advanced biliary tract carcinoma: Multicenter, multinational study.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.e14653
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. e14653-e14653
◽
Cited By ~ 3
Author(s):
J. Yi
◽
S. Thongprasert
◽
D. Doval
◽
J. Lee
◽
M. N. Cho
◽
...
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Phase Ii Study
◽
Biliary Tract Carcinoma
◽
Multinational Study
◽
Line Treatment
◽
Second Line
Download Full-text
Related Documents
Cited By
References
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
European Journal of Cancer
◽
10.1016/j.ejca.2011.11.017
◽
2012
◽
Vol 48
(2)
◽
pp. 196-201
◽
Cited By ~ 74
Author(s):
Jun Ho Yi
◽
Sumitra Thongprasert
◽
Jeeyun Lee
◽
D.C. Doval
◽
Se Hoon Park
◽
...
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Phase Ii Study
◽
Biliary Tract Carcinoma
◽
Multinational Study
◽
Line Treatment
◽
Second Line
Download Full-text
Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer
Annals of Oncology
◽
10.1093/annonc/mdy282.142
◽
2018
◽
Vol 29
◽
pp. viii259
Author(s):
J.S. Yoon
◽
K.-H. Lee
◽
G.J. Cheon
◽
Y.-J. Bang
◽
D.-Y. Oh
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Tract Cancer
Download Full-text
Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study
Onkologie
◽
10.1159/000331065
◽
2011
◽
Vol 34
(8)
◽
pp. 469-470
◽
Cited By ~ 13
Author(s):
Annekathrin Roth
◽
Eberhard Schleyer
◽
Konrad Schoppmeyer
◽
Regine Kluge
◽
Christian Wittekind
◽
...
Keyword(s):
Imatinib Mesylate
◽
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Tract Cancer
Download Full-text
Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-017-3461-z
◽
2017
◽
Vol 80
(6)
◽
pp. 1189-1196
◽
Cited By ~ 4
Author(s):
Satoshi Kobayashi
◽
Makoto Ueno
◽
Kazuya Sugimori
◽
Chigusa Morizane
◽
Yasushi Kojima
◽
...
Keyword(s):
Dose Rate
◽
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Fixed Dose
◽
Line Treatment
◽
Second Line
◽
Tract Cancer
◽
Fixed Dose Rate
Download Full-text
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-015-2691-1
◽
2015
◽
Vol 75
(4)
◽
pp. 757-762
◽
Cited By ~ 3
Author(s):
In Gyu Hwang
◽
Joung-Soon Jang
◽
Sung Yong Oh
◽
Myung Hwan Rho
◽
Suee Lee
◽
...
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Tract Cancer
Download Full-text
Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study
Oncology
◽
10.1159/000479970
◽
2017
◽
Vol 94
(1)
◽
pp. 19-24
◽
Cited By ~ 10
Author(s):
Finn Ole Larsen
◽
Alice Markussen
◽
Laura V. Diness
◽
Dorte Nielsen
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Efficacy And Safety
◽
Tract Cancer
Download Full-text
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
Journal of Neurosurgical Sciences
◽
10.23736/s0390-5616.16.03874-1
◽
2019
◽
Vol 63
(4)
◽
Cited By ~ 7
Author(s):
Salvatore Grisanti
◽
Vittorio D. Ferrari
◽
Michela Buglione
◽
Giorgio M. Agazzi
◽
Roberto Liserre
◽
...
Keyword(s):
Systematic Review
◽
Phase Ii
◽
Phase Ii Study
◽
Recurrent Glioblastoma
◽
Line Treatment
◽
Second Line
◽
Review Of Literature
Download Full-text
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group
Cancer Science
◽
10.1111/j.1349-7006.2011.01909.x
◽
2011
◽
Vol 102
(6)
◽
pp. 1171-1175
◽
Cited By ~ 20
Author(s):
Hiroshi Kitamura
◽
Keisuke Taguchi
◽
Yasuharu Kunishima
◽
Masahiro Yanase
◽
Atsushi Takahashi
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Metastatic Urothelial Carcinoma
Download Full-text
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)
ESMO Open
◽
10.1016/j.esmoop.2021.100314
◽
2022
◽
Vol 7
(1)
◽
pp. 100314
Author(s):
M.M. Javle
◽
D.-Y. Oh
◽
M. Ikeda
◽
W.-P. Yong
◽
K. Hsu
◽
...
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Second Line
◽
Tract Cancer
◽
Randomized Phase Ii
Download Full-text
P-524 Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: Phase II study
Lung Cancer
◽
10.1016/s0169-5002(05)81017-7
◽
2005
◽
Vol 49
◽
pp. S255
Author(s):
S. Lee
◽
E. Lee
◽
H. Jeong
◽
S. Lee
◽
J. Kim
◽
...
Keyword(s):
Phase Ii
◽
Lung Carcinoma
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Cell Lung Carcinoma
◽
Nonsmall Cell Lung Carcinoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close